壁层上皮细胞盐皮质激素受体抑制可预防局灶节段性肾小球硬化及新月体性肾小球肾炎
该研究在小鼠模型中探讨壁层上皮细胞(PEC)盐皮质激素受体(MR)信号的作用。结果显示,PEC特异性敲除MR或使用依普利酮均可预防DOCA-盐加单肾切除后的PEC迁移和增殖,并在肾毒血清诱导的新月体性肾小球肾炎中预防肾外病变和肾小球衰竭。研究提示MR信号在FSGS和新月体性肾小球肾炎中具有共同作用,支持MR拮抗剂作为潜在辅助治疗。
要点
- PEC特异性敲除MR可预防DOCA-盐加单肾切除后的PEC迁移和增殖。
- 依普利酮可预防肾毒血清诱导的新月体性肾小球肾炎的肾外病变和肾小球衰竭。
- MR信号与HB-EGF及其受体信号通路存在显著重叠,促进PEC迁移、增殖和上皮间质转化。
核心结论
- MR信号在FSGS和新月体性肾小球肾炎等肾外肾小球病的病理生理中具有共同作用,支持MR拮抗剂作为具有原创作用模式的潜在辅助治疗药物用于严重疾病。
研究设计与样本
- 研究采用两种涉及PEC激活的小鼠肾小球疾病模型:DOCA-盐加单肾切除的适应不良性FSGS模型,以及肾毒血清诱导的新月体性肾小球肾炎模型。
主要发现
- 在DOCA-盐加单肾切除后,PEC特异性靶向MR(Nr3c2)基因可预防PEC迁移和增殖。
- 在肾毒血清诱导的新月体性肾小球肾炎中,PEC敲除MR和使用依普利酮进行药理学阻断均能有效预防肾外病变和肾小球衰竭。
- HB-EGF及其受体信号与MR信号触发的通路之间存在显著重叠,促进PEC迁移、增殖和上皮间质转化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Focal segmental glomerulosclerosis (FSGS) is a common histological lesion in adults worldwide. It results from initial podocyte injury, followed by a maladaptive activation of glomerular parietal epithelial cells (PECs), which leads to progressive scarring of glomeruli. Abnormal PEC phenotype is also a hallmark of crescentic glomerulonephritides, another class of severe kidney diseases that complicate small vessel vasculitides. Current knowledge of the pathophysiological mechanisms leading to PEC activation is limited. Recent evidence indicates an active and destructive role for PECs in extra-capillary glomerular diseases. Therefore, targeting such maladaptive responses could represent a novel therapeutic option to prevent kidney failure in patients. Yet, druggable pathways to prevent or stop the pathogenic behavior of PECs are still elusive. METHODS: Here, we examined the role of the mineralocorticoid receptor signaling in PECs in two mouse models of glomerular disease involving PEC activation: a robust model of maladaptive FSGS with deoxycorticosterone acetate (DOCA)-salt administration with uninephrectomy, and nephrotoxic serum-induced crescentic glomerulonephritis. RESULTS: We demonstrate that targeting the mineralocorticoid receptor (MR) (Nr3c2) gene specifically in PECs prevents migration and proliferation after DOCA-salt administration with uninephrectomy. Remarkably, both MR deficiency in PECs and mineralocorticoid receptor pharmacological blockade using eplerenone were also effective in preventing extracapillary lesions and glomerular failure in nephrotoxic serum-induced crescentic glomerulonephritis. Additionally, we revealed a significant overlap between pathways triggered by heparin-binding EGF-like growth factor and its receptor signaling and MR signaling. This promoted the migration, proliferation, and epithelial-to-mesenchymal transition of PECs. CONCLUSIONS: Together, our results highlight the common role of MR signaling in the pathophysiology of extra-capillary glomerulopathies, FSGS, and crescentic glomerulonephritis. This supports the use of MR antagonists as potential complementary therapeutic agents with original modes of action for severe diseases.
引用
- Lazareth H, Lenoir O, Garo F, et al. Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis. Kidney Int. 2025. PMID: 41005568. doi:10.1016/j.kint.2025.07.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。